首页> 外文OA文献 >A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial

【2h】

A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial

机译：一种基于硼替佐米的方案可在骨髓分离性HLA不匹配和无关的供体移植中提供有希望的生存和移植物抗宿主疾病的预防：II期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Koreth John; Kim Haesook T.; Lange Paulina B.; Bindra Bhavjot; Reynolds Carol G.; Chammas Marie J.; Armand Philippe; Cutler Corey S.; Ho Vincent T.; Glotzbecker Brett; Nikiforow Sarah; Ritz Jerome; Blazar Bruce R.; Soiffer Robert J.; Antin Joseph H.; Alyea Edwin P.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial [J] . Koreth John, Kim Haesook T., Lange Paulina B., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第11期

机译：一种基于硼替佐米的方案可在骨髓分离性HLA不匹配和无关的供体移植中提供有希望的生存和移植物抗宿主病的预防：II期试验
2. Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation [J] . KorethJ., StevensonK.E., KimH.T., Journal of Clinical Oncology . 2012,第26期

机译：HLA失配无关供体移植中基于硼替佐米的移植物抗宿主病的预防
3. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial. [J] . Wagner JE, Thompson JS, Carter SL, The Lancet . 2005,第9487期

机译：预防移植物抗宿主疾病对无关供者骨髓接受者3年无病生存的影响（T细胞耗竭试验）：一项多中心，随机的II-III期试验。
4. Anti-Thymocyte-Globulin (ATG-Fresenius) for Prevention of Acute and Chronic Graft-versus-Host Disease in Pediatric and Adult Recipients of Unrelated Donor Bone Marrow Transplantation [C] . . 2006

机译：抗胸腺细胞球蛋白（ATG-Fresenius）预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
5. A comparison of methods for estimating survival probabilities in two stage phase III randomized clinical trials. [D] . Wang, Ying. 2009

机译：在两个阶段的III期随机临床试验中比较评估生存概率的方法。
6. A Bortezomib-based Regimen Offers Promising Survival and Graft-vs.-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial [O] . John Koreth, Haesook T. Kim, Paulina B. Lange, -1

机译：一种基于硼替佐米的方案可在骨髓清除性HLA不匹配和无关的供体移植中提供有希望的生存率和移植物抗宿主病的预防：II期试验
7. A Prospective Phase I/II Trial of Bortezomib-Based Graft-Versus-Host-Disease Prophylaxis in HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation: Encouraging Safety, Efficacy, and Survival [O] . Koreth J., Stevenson K.E., Kim H.T., 2011

机译：在HLA不匹配的无关供体降低强度条件下进行造血干细胞移植的基于硼替佐米的移植物抗宿主病预防的前瞻性I / II期试验：鼓励安全性，疗效和存活率

A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial

著录项

相似文献

相关主题

期刊订阅